Linz, Austria

Harald Fellier

This inventor holds 3 USPTO granted patents. Top assignees: Nycomed Austria Gmbh, Cl Pharma Aktiengesellschaft. Active years: 1991-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harald Fellier. Retrieved from https://idiyas.com/inventor/harald-fellier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Puchenau, AT (1991)
  • Linz, AT (1999 - 2001)

Company Filing History:


Years Active: 1991-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Harald Fellier

Introduction

Harald Fellier is a notable inventor based in Linz, Austria, recognized for his contributions to the field of pharmaceuticals. With a total of three patents to his name, he has made significant strides in the development of compounds that target specific enzymes.

Latest Patents

Fellier's latest patents include "Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase II." This application relates to compounds of a specific formula, wherein A represents oxygen, sulfur, or nitrogen, and includes a detailed process for their preparation. These compounds are particularly noteworthy for their use in inhibiting cyclooxygenase II, an enzyme involved in inflammatory processes.

Career Highlights

Throughout his career, Fellier has worked with prominent companies in the pharmaceutical industry, including Nycomed Austria GmbH and Cl Pharma Aktiengesellschaft. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Fellier has collaborated with esteemed colleagues such as Heinz Blaschke and Peter Kremminger, further enhancing the impact of his research and innovations.

Conclusion

Harald Fellier's work exemplifies the spirit of innovation in the pharmaceutical field, with his patents paving the way for new therapeutic options. His contributions continue to influence the industry and inspire future research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…